On April 25, Gelonghui | Saisheng Pharmaceutical (300485.SZ) released its first quarter report. Operating revenue was 110 million yuan, down 17.46% year on year, net loss was 190 million yuan, turning loss year on year. After deducting non-net profit of 15.1578 million yuan, up 383.81% year on year, and basic earnings per share -0.3957 yuan.
赛升药业(300485.SZ)：一季度净亏损1.9亿元 同比转亏
Saisheng Pharmaceutical (300485.SZ): Net loss of 190 million yuan in the first quarter turned into a year-on-year loss
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.